Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 7/20 | 0.40 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.40 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.40 |
| ▸ | GGH | Q92820 | 1/20 | 0.35 |
| ▸ | BMP1 | P13497 | 2/20 | 0.35 |
| ▸ | FNTA | P49354 | 2/20 | 0.33 |
| ▸ | FNTB | P49356 | 2/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24622228 | 0.88 | HPGDS (0.41) | FOLH1NAALAD2RIMKLA | |
| SCHEMBL23289285 | 0.86 | PSMB5 (0.42) | FOLH1NAALAD2RIMKLAGGHBMP1 | |
| SCHEMBL25129089 | 0.85 | FOLH1 (0.38) | FOLH1NAALAD2RIMKLAGGHBMP1 | |
| SCHEMBL25128949 | 0.85 | FOLH1 (0.38) | FOLH1NAALAD2RIMKLAGGHBMP1 | |
| SCHEMBL25128148 | 0.83 | PSMB5 (0.47) | FOLH1NAALAD2RIMKLABMP1 | |
| SCHEMBL24622679 | 0.77 | FOLH1 (0.35) | FOLH1NAALAD2RIMKLAGGHBMP1 | |
| SCHEMBL26173989 | 0.76 | FOLH1 (0.47) | FOLH1NAALAD2RIMKLAGGHBMP1 | |
| SCHEMBL468800 | 0.76 | FOLH1 (0.59) | FOLH1NAALAD2RIMKLAGGHFNTA | |
| SCHEMBL12648688 | 0.76 | FOLH1 (0.59) | FOLH1NAALAD2RIMKLAGGHFNTA | |
| SCHEMBL468801 | 0.76 | FOLH1 (0.59) | FOLH1NAALAD2RIMKLAGGHFNTA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023040793-A1 | ANTI-INFLAMMATORY COMPOUND AND USE THEREOF | 映恩生物制药（苏州）有限公司 | 2023-03-23 | — | — | WO | disclosed |